Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
about
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature.A new approach to control the enigmatic activity of aldose reductase.Quantitative evaluation of aldo-keto reductase expression in hepatocellular carcinoma (HCC) cell lines.Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.Identification of secreted proteins that reflect autophagy dynamics within tumor cells.Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathwayEditorial on research topic: aldo-keto reductases and role in human disease.Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity.Aldose reductase interacts with AKT1 to augment hepatic AKT/mTOR signaling and promote hepatocarcinogenesis.Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.Aldo-Keto Reductases Mediated Cytotoxicity of 2-Deoxyglucose: A Novel Anticancer Mechanism.Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.Stereospecific Metabolism of R- and S-Warfarin by Human Hepatic Cytosolic Reductases.Integrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma
P2860
Q33600379-F743AC30-5B2B-46E1-A08B-7744F5B0AEEEQ33918123-9C71041C-CD3F-473D-AA36-C6F6FF043176Q34982833-7292A76E-BED6-465A-B64A-FA3870EA74FCQ35171770-ED92987A-62E3-4EE7-A6F6-11B75EA78B27Q36585331-006864EC-1E4C-4799-8D50-A4AA4BD58BB1Q36656870-4D7E6336-EA48-4DD4-B990-C746917A9F0AQ38931162-FC98C6A2-EF72-4332-82BD-466992C4D23EQ38949016-0BEEDFB7-6F48-474D-9106-F523053CDC80Q40870170-CA9285B4-CCD6-41AF-BBBB-89C7E93A3B90Q41943341-FAAFE57D-9DA3-4B74-8FCD-693A3F317339Q42366521-30258949-60CB-4E4D-B33C-D8CD9872AB9EQ48116483-65E1C9C1-A67D-4E11-A45E-6370B442A6E3Q52607803-DB3DE00A-C5FE-465C-A404-AF55EBF6C290Q52755069-7EE39208-4A64-46A4-AD91-78F32718AD6FQ54158178-4529D46B-8015-4AB8-8998-EB3F96EE5623Q58733819-47A0E1D2-9B52-4F19-9A3D-63C591C00BF4
P2860
Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
@en
type
label
Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
@en
prefLabel
Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
@en
P2860
P356
P1476
Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
@en
P2093
Brian Laffin
J Mark Petrash
P2860
P356
10.3389/FPHAR.2012.00104
P577
2012-06-06T00:00:00Z